Health Herald Grenada: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Herald Grenada.

Press releases published on October 1, 2026

4 hours ago

Wave Life Sciences Announces FDA Feedback Supports Registrational Pathway for WVE-006 (RNA Editing) in AATD

Indeterminate GlobeNewswire

4 hours ago

Arbutus Announces Final Results of Its US$230 Million Modified “Dutch Auction” Tender Offer

Indeterminate GlobeNewswire

4 hours ago

InflaRx Appoints Gabriela Alperovich, MD, PhD, as Senior Vice President & Global Head of Clinical Development

Indeterminate GlobeNewswire

4 hours ago

Galimedix Therapeutics presents baseline data from Phase 2 eDREAM trial highlighting patient-tailored microperimetry as a sensitive and precise functional measurement in geographic atrophy studies

Indeterminate GlobeNewswire

5 hours ago

Sight Sciences to Debut the OMNI Ultra® Surgical System, the Latest Technology Advancement from the Pioneers of Ab Interno Canaloplasty, at the 2026 American Academy of Ophthalmology (AAO) Annual Meeting

Indeterminate GlobeNewswire

5 hours ago

OrthoPediatrics Sponsors the 10th Pediatric Orthopedic Surgical Techniques Course

Indeterminate GlobeNewswire

5 hours ago

Caspian Therapeutics Appoints Manasi Jaiman, M.D., M.P.H., and Elizabeth Mily to Board of Directors

Indeterminate GlobeNewswire

5 hours ago

MitoRx Therapeutics presents new preclinical data on MTRX31, demonstrating restored mitochondrial density, at the 62nd EASD Annual Meeting

Indeterminate GlobeNewswire

5 hours ago

What Are the 5 Signs of Poor Metabolic Health Adults May Overlook?

Indeterminate GlobeNewswire

5 hours ago

Ocular Therapeutix™ to Participate in October Scientific and Investor Conferences

Indeterminate GlobeNewswire

5 hours ago

Monte Rosa Therapeutics Announces Positive Results for MRT-8102 in GFORCE-1 Phase 1 Study Showing Normalization of Key Pathogenic Drivers of ASCVD in Subjects with Elevated CVD Risk

Indeterminate GlobeNewswire

5 hours ago

Foghorn Therapeutics Provides Update on FHD-909 and Strategic Priorities

Indeterminate GlobeNewswire

5 hours ago

Shattuck Labs Announces Phase 2 Clinical Trial of SL-325 in Hidradenitis Suppurativa and Appointment of Shoba Ravichandran, M.D., as Senior Vice President, Clinical Development

Indeterminate GlobeNewswire

5 hours ago

Fate Therapeutics to Participate in Upcoming Fourth Quarter 2026 Conferences

Indeterminate GlobeNewswire

5 hours ago

Kyntra Bio Appoints Andrew E. Singer, MBA to its Board of Directors

Indeterminate GlobeNewswire

5 hours ago

Iovance Biotherapeutics Appoints Noah Berkowitz, M.D., Ph.D., as Chief Medical Officer

Indeterminate GlobeNewswire

5 hours ago

Roswell Park, Generate Biomedicines Launch Exclusive Clinical Trial of ‘Armored’ CAR T Therapy for Ovarian Cancer

Indeterminate GlobeNewswire

5 hours ago

BioStem Technologies Strengthens Placental Allograft and Umbilical Tissue Patent Portfolio

Indeterminate GlobeNewswire

5 hours ago

Canadians Invited to “Carry the Weight” this October – For Kids Like Hamdiya

Indeterminate GlobeNewswire

5 hours ago

Kailera Therapeutics Presents New Clinical Data at EASD 2026 Annual Meeting

Indeterminate GlobeNewswire